Long-term facial nerve function following facial reanimation after translabyrinthine vestibular schwannoma surgery: A comparison between sural grafting and VII-XII anastomosis
- Authors:
- Published online on: May 16, 2013 https://doi.org/10.3892/etm.2013.1120
- Pages: 101-104
Abstract
Introduction
Vestibular schwannoma surgery is currently performed with low morbidity and mortality rates due to improvements in diagnostic capabilities and advances in perioperative monitoring and microsurgical techniques (1). Intraoperative facial nerve interruption may be minimized, but remains an inevitable complication (2,3), particularly for patients with certain types of large tumors or recurrent tumors following stereotactic irradiation (4–7). The most common techniques for facial reanimation are sural grafting and hypoglossal-facial (VII–XII) anastomosis. It has been reported that these techniques produce excellent results, as assessed by the House-Brackmann grade of facial function, but to date there has been no long-term comparison of the techniques (6).
The aim of the current study was to compare the short-and long-term facial recovery results and surgical outcomes of patients who had undergone sural grafting and VII–XII anastomosis for the reanimation of interrupted facial nerves during the removal of translabyrinthine vestibular schwannomas.
Patients and methods
Subject selection
All vestibular schwannoma surgeries performed by surgeons at Xinhua Hospital (Shanghai, China) between 2003 and 2006 were screened for the following selection criteria: i) translabyrinthine total tumor removal; ii) normal preoperative facial nerve function (House-Brackmann grade); iii) interruption of the facial nerve during surgery and immediate reanimation by sural graft or VII–XII anastomosis; and iv) data available at all postoperative points in time (upon discharge from the hospital, at one year, and at three years following surgery). These criteria were met in 25 cases. These patients became the subjects of this study. Written informed consent was obtained from patents and their families. The study was approved by the Ethics Committee of Xinhua Hospital.
Patient characteristics
The characteristics of the patients in the two groups are shown in Table I. There were no statistically significant differences in the mean age or tumor size.
The patients were divided into two groups, odd and even according to the last number of their ID. Odd patients received sural graft facial reanimation and even patients received VII–XII anastomosis. The four patients in whom it was not possible to identify the proximal stumps of the facial nerves were placed in the even group.
Facial function and surgical data
Facial function and surgical data were obtained from Xinhua Hospital records. Patients who underwent vestibular schwannoma removal were routinely followed up for facial function and surgical outcome by interview approximately one and three years following surgery. All data were accessible for the purpose of this study.
Follow-up
During the follow-up period, any complications developed by the facial reanimation patients, such as synkinesia, claudication, disarticulation, numbness of the tongue and dysphagia, were assessed.
Statistical analysis
Statistical comparisons were performed using parametric and non-parametric tests, as appropriate. Assessments were performed using two-tailed probabilities. P<0.05 was considered to indicate a statistically significant difference. Statements showing no difference between groups indicate that a statistical test was performed and failed to reject the null hypothesis.
Results
Observations at discharge
House-Brackmann facial grade VI function was observed in all 25 patients upon discharge. Significant recovery of facial nerve function was observed at both postoperative time intervals: one year (short term) and three years (long term). Facial nerve grades for the two groups at the short- and long-term intervals are shown in Fig. 1 and Table II. There was a statistically significant difference in facial nerve recovery between the short- and long-term follow-up in the two treatment groups. In the sural graft group, House-Brackmann grade III facial function was achieved in four (30.8%) and ten (76.9%) patients in the short and long term, respectively, and House-Brackmann grade IV facial function was achieved in nine (69.2%) and three (23.1%) patients in the short and long term, respectively. There was a statistically significant difference between the facial recovery results across the short- and long-term follow-up periods in the sural graft group (P=0.036). In the VII-XII anastomosis group, House-Brackmann grade III facial function was achieved in two (16.7%) and eight (66.7%) patients in the short and long term, respectively and House-Brackmann grade IV facial function was achieved in ten (83.3%) patients in the short term and four (33.3%) patients in the long term. There was a statistically significant difference between the facial recovery results across the short- and long-term follow-up periods (P=0.047).
Observations at follow-up
A comparison of the facial recovery results of the techniques revealed that, upon short-term follow-up, House-Brackmann grade III facial function was achieved in four (30.8%) and two (16.7%) cases in the sural graft and VII–XII anastomosis groups, respectively. Upon long-term follow-up, House-Brackmann grade III facial function was achieved in ten (76.9%) and eight (66.7%) cases in the sural graft and VII–XII anastomosis groups, respectively. It appeared that facial nerve function recovery was improved in the sural graft group compared with the VII–XII anastomosis group in both the short- and long-term follow-up, but no statistically significant difference was observed between the groups (short term, P=0.645; long term, P=0.673).
Some special outcomes following facial animation were observed during postoperative follow-up. In the sural graft group, claudication was common upon discharge (four patients), but diminished over time. Synkinesia, the most common cause of complaint, was observed in three patients. In the VII–XII anastomosis group, disarticulation was the most common complication, observed in five patients. Numbness of the tongue was the second most common complication, observed in four patients. None of the patients developed dysphagia and synkinesia.
Discussion
In this type of large tumor, total tumor removal is achieved exclusively through the translabyrinthine approach (8,9). The translabyrinthine approach allows a positive identification of the distal segment of the facial nerve (10). Dissection of the plane between the tumor capsule and the facial nerve may then be extended medially (11). Following tumor debulking and the positive identification of the proximal facial nerve at the surface of the brain stem, the plane may be established medially. Combined medial and lateral identification provides the maximal possibility of preserving nerve integrity (12,13). It has been reported that particularly poor facial outcomes are observed in patients who required the surgical excision of previously irradiated vestibular schwannomas (14–16).
The incidence of facial nerve interruption has been reduced significantly due to improvements in surgical techniques and perioperative monitoring. It has been reported that automatic facial nerve preservation is achieved in >90% of large vestibular schwannoma patients. However, a certain degree of facial interruption is inevitable, particularly in patients with large or recurrent tumors (17).
Various techniques may be used for facial reanimation depending on the characteristic of the proximal stump of the facial nerve and the preference of the surgeon (18). Sural graft and VII–XII anastomosis are the most common facial reanimation techniques. Both surgeries provide the possibility of House-Brackmann grade III facial recovery in the long term. These techniques have advantages and disadvantages. The sural nerve has a history of use as a donor nerve, but there is evidence that motor nerve grafts are more appropriate than sensory nerve grafts (19). Acquisition of a sural cable may not necessarily extend the surgical period. With sural nerve grafting, the best outcome is House-Brackmann grade III facial function (20). Claudication is the most common complication at the time of discharge, but it quickly fades. Synkinesia is the most prominent complication of sural graft facial reanimation. VII–XII anastomosis may be achieved by a single surgical incision and does not require the identification of the proximal facial stump. The disadvantage of VII–XII anastomosis is that it sacrifices the function of the hypoglossal nerve (21). Disarticulation and numbness of the tongue are the most common complaints during follow-up. The best possible facial recovery is House-Brackmann grade III.
This study compared patients who underwent surgery during the same period by surgeons with the same level of experience. The mean patient age was 46.69 years in the sural graft group and 47.00 years in the VII–XII anastomosis group. No statistical difference in age was detected between the groups. Tumor size is the most important factor affecting facial function following surgery. The mean tumor size was 3.15 cm in the sural graft group and 3.08 cm in the VII–XII anastomosis group. No statistically significant difference was detected between the groups with regard to tumor size.
We compared the short- and long-term outcomes of facial reanimation. In the sural graft group, House-Brackmann grade III facial function was achieved in four patients in the short term and in ten patients in the long term. House-Brackmann grade IV facial function was achieved in nine patients in the short term and in three patients in the long term. In the VII–XII anastomosis group, House-Brackmann grade III facial function was achieved in two patients in the short term and eight patients in the long term. House-Brackmann grade IV facial function was achieved in ten patients in the short term and in four patients in the long term. There was a statistically significant difference between the facial recovery results across the short- and long-term follow-up periods. The outcomes of facial reanimation were acceptable following sural grafting and VII–XII anastomosis.
We compared the long-term outcomes of facial recovery following the different surgical facial reanimation techniques. Sural grafting appeared to produce superior facial recovery compared with VII–XII anastomosis in the short term (House-Brackmann grade III 30.8 vs. 16.7%) and in the long term (House-Brackmann grade III 76.9 vs. 66.7%). However, no statistically significant difference was observed between the surgical groups. Selecting the appropriate surgical technique for facial reanimation requires careful consideration of the complications and benefits of all available surgeries. A study sampling a greater number of patients may provide further insight into the value of various surgical procedures.
Following surgery, synkinesia developed in 23.1% (3/13) of sural graft cases in the present study. No significant synkinesia was observed in the VII–XII anastomosis group. This observation is explained by the fact that the healing of two nerves led to a greater incidence of incorrect regeneration by the facial nerve fibers (22).
Loss of function of the hypoglossal nerve led to numbness of the tongue and disarticulation, which was occasionally accompanied by severe facial paresis. Following surgery, rehabilitation training of the hypoglossal and facial nerves may improve functional recovery.
In conclusion, facial reanimation remains an effective procedure for the surgical rehabilitation of static and dynamic facial nerve functions. A significant improvement in facial nerve function may occur more than three years following surgery. Despite such morbidities as synkinesia, the sural graft technique is accompanied by a greater improvement in facial nerve function compared with VII–XII anastomosis in both the short- and long-term evaluations, but this requires confirmation by larger studies.
References
Theodosopoulos PV and Pensak ML: Contemporary management of acoustic neuromas. Laryngoscope. 121:1133–1137. 2011. View Article : Google Scholar : PubMed/NCBI | |
Falcioni M, Fois P, Taibah A and Sanna M: Facial nerve function after vestibular schwannoma surgery. J Neurosurg. 115:820–826. 2011. View Article : Google Scholar : PubMed/NCBI | |
Han SJ, Oh MC, Sughrue ME, Aranda D, Rutkowski MJ and Parsa AT: Reporting standard compliance in publications of vestibular schwannoma patients treated with microsurgery. Otol Neurotol. 33:648–650. 2012. View Article : Google Scholar : PubMed/NCBI | |
Giordano AI, Domènech I, Torres A, et al: Results in the surgical treatment of giant acoustic neuromas. Acta Otorrinolaringol Esp. 63:194–199. 2012.(In Spanish). | |
Bambakidis NC, Lo SS and Selman WR: Large vestibular schwannomas. J Neurosurg. 115:894–895. 2011. View Article : Google Scholar : PubMed/NCBI | |
Nuseir A, Sequino G, De Donato G, Taibah A and Sanna M: Surgical management of vestibular schwannoma in elderly patients. Eur Arch Otorhinolaryngol. 269:17–23. 2012. View Article : Google Scholar : PubMed/NCBI | |
Ahmad RA, Sivalingam S, Topsakal V, Russo A, Taibah A and Sanna M: Rate of recurrent vestibular schwannoma after total removal via different surgical approaches. Ann Otol Rhinol Laryngol. 121:156–161. 2012. View Article : Google Scholar : PubMed/NCBI | |
Ben Ammar M, Piccirillo E, Topsakal V, Taibah A and Sanna M: Surgical results and technical refinements in translabyrinthine excision of vestibular schwannomas: the Gruppo Otologico experience. Neurosurgery. 70:1481–1491. 2012.PubMed/NCBI | |
Mamikoglu B, Esquivel CR and Wiet RJ: Comparison of facial nerve function results after translabyrinthine and retrosigmoid approach in medium-sized tumors. Arch Otolaryngol Head Neck Surg. 129:429–431. 2003. View Article : Google Scholar : PubMed/NCBI | |
Kim J, Moon IS, Jeong JH, Lee HR and Lee WS: What really decides the facial function of vestibular schwannoma surgery? Clin Exp Otorhinolaryngol. 14:168–173. 2011. View Article : Google Scholar : PubMed/NCBI | |
Gerganov VM, Giordano M, Samii M and Samii A: Diffusion tensor imaging-based fiber tracking for prediction of the position of the facial nerve in relation to large vestibular schwannomas. J Neurosurg. 115:1087–1093. 2011. View Article : Google Scholar : PubMed/NCBI | |
Charpiot A, Tringali S, Zaouche S, Ferber-Viart C and Dubreuil C: Perioperative complications after translabyrinthine removal of large or giant vestibular schwannoma: Outcomes for 123 patients. Acta Otolaryngol. 130:1249–1255. 2010. View Article : Google Scholar | |
Angeli RD, Ben Ammar M and Sanna M: Perioperative complications after translabyrinthine removal of large or giant vestibular schwannoma: outcomes for 123 patients. Acta Otolaryngol. 131:1237–1238. 2011. | |
Collen C, Ampe B, Gevaert T, et al: Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience. Int J Radiat Oncol Biol Phys. 81:e503–e509. 2011. View Article : Google Scholar | |
Friedman RA, Berliner KI, Bassim M, et al: A paradigm shift in salvage surgery for radiated vestibular schwannoma. Otol Neurotol. 32:1322–1328. 2011. View Article : Google Scholar : PubMed/NCBI | |
Gerganov VM, Giordano M, Samii A and Samii M: Surgical treatment of patients with vestibular schwannomas after failed previous radiosurgery. J Neurosurg. 116:713–720. 2012. View Article : Google Scholar : PubMed/NCBI | |
Hertzano R and Eisenman DJ: Large, symptomatic tension pneumocele: 23 years after translabyrinthine resection of an acoustic neuroma. Otolaryngol Head Neck Surg. 144:477–478. 2011.PubMed/NCBI | |
Guntinas-Lichius O, Straesser A and Streppel M: Quality of life after facial nerve repair. Laryngoscope. 117:421–426. 2007. View Article : Google Scholar : PubMed/NCBI | |
Samii M, Koerbel A, Safavi-Abbasi S, Di Rocco F, Samii A and Gharabaghi A: Using an end-to-side interposed sural nerve graft for facial nerve reinforcement after vestibular schwannoma resection. Technical note. J Neurosurg. 105:920–923. 2006. View Article : Google Scholar : PubMed/NCBI | |
Humphrey CD and Kriet JD: Nerve repair and cable grafting for facial paralysis. Facial Plast Surg. 24:170–176. 2008. View Article : Google Scholar : PubMed/NCBI | |
Magliulo G, D’Amico R, Forino M and Marcotullio D: Facial reanimation: a proposal to reduce postoperative morbidity. Laryngoscope. 112:183–186. 2002. View Article : Google Scholar : PubMed/NCBI | |
Filipo R, Spahiu I, Covelli E, Nicastri M and Bertoli GA: Botulinum toxin in the treatment of facial synkinesis and hyper-kinesis. Laryngoscope. 122:266–270. 2012. View Article : Google Scholar : PubMed/NCBI |